Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 …

Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 …

C La Rosa, J Longmate, SF Lacey… - Journal of Infectious …, 2012 - academic.oup.com

... Article Navigation. Clinical Evaluation of Safety and Immunogenicity of
PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With
or Without PF03512676 Adjuvant. Corinna La Rosa Corinna La Rosa. ...

Peptide synthesis, peptide modification and peptide library synthesis, please contact:

Eva He

eva@pepmic.com

Pepmic Co., Ltd

www.pepmic.com